来自:中国糖尿病杂志 编辑:夏文清 黄艳 周祎 王少华|点击数:|2013-09-26
·讲座·
【摘要】大量研究发现糖尿病患者患阿尔茨海默病(AD)风险增高,两种疾病联系的潜在机制尚未阐明。胰岛素增敏剂及新型长效胰升血糖素样肽-1 (GLP-1)类似物已用于临床,可改善糖尿病患者认知障碍。
【关键词】糖尿病;阿尔茨海默病;认知障碍
Relationship between diabetes and Alzheimer’s Disease and its research progress XIA Wen-qing, HUANG Yan, ZHOU Wei, et al. Department of Endocrinology, The Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China
Corresponding author: WANG Shao-hua, E-mail: gyjwsh@yahoo.cn
【Summary】 Numerous studies have demonstrated that diabetic patients have an increased risk of developing Alzheimer’s Disease (AD). The potential mechanism in linking DM with AD is not fully elucidated. Insulin sensitizers and novel long-effect glucagon-like peptide -1 (GLP-1) analogues have been applied to clinic to alleviate the cognitive dysfunction related to diabetes.
【Key words】Diabetes mellitus; Alzheimer’s disease; Cognitive impairment
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想